secwatch / observer
8-K filed June 18, 2026, 5:00 PM ET ticker ZURA CIK 0001855644
other material confidence high sentiment neutral materiality 0.50

Shareholders approve amended equity plan at annual meeting, re-elect directors

Zura Bio Ltd

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Zura Bio Ltd shareholders approved Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 2 - Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company's shareholders ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast were as follows: For Against Abstain 74,323,697 30,527 193,928
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Zura Bio Ltd shareholders approved Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan at the 2026-06-17 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 3 - Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan The Company's shareholders approved the amendment and restatement of the Company's 2023 Equity Incentive Plan. The votes cast were as follows: For Against Abstain Broker Non-Votes 38,850,373 17,403,607 26,663 18,267,509
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Zura Bio Ltd shareholders approved Election of eight director nominees at the 2026-06-17 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 1 - Election of Directors. The Company's shareholders elected the Director Nominees as directors of the Company, each to hold office until the next annual general meeting of shareholders or until their respective successors have been elected and qualified, or until their earlier death, resignation or removal. The votes cast were as follows: Nominee For Against Abstain Broker Non-Votes Daniel Becker 55,968,512 291,173 20,958 18,267,509 Mark Eisner 56,209,068 49,466 22,109 18,267,509 Jennifer Jarrett 39,788,639 16,471,044 20,958 18,267,511 Sandeep Kulkarni 56,250,391 8,292 21,960 18,267,509 Amit Munshi 40,229,829 16,027,697 23,115 18,267,511 Ajay Nirula 56,249,212 8,319 23,113 18,267,508 Steven Schoch 56,197,526 61,025 22,093 18,267,508 Parvinder Thiara 55,766,669 490,857 23,115 18,267,511
View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Zura Bio Ltd filing history →

Source: SEC EDGAR
accession 0001104659-26-075826
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.